Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹500 Cr₹511 Cr₹393 Cr₹367 Cr₹391 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹500 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹500 Cr
Mar2023₹511 Cr
Mar2022₹393 Cr
Mar2021₹367 Cr
Mar2020₹391 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2024 ₹500 Cr
-2.26
Mar2023 ₹511 Cr
30.23
Mar2022 ₹393 Cr
6.82
Mar2021 ₹367 Cr
-6.11
Mar2020 ₹391 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹888.2 Cr 1.5% -8% -7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,682.0 Cr -2% 2% -16.2% Stock Analytics
DIVIS LABORATORIES ₹150,985.0 Cr -5% -6.6% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,862.0 Cr -0.4% 0.5% 5.2% Stock Analytics
CIPLA ₹121,294.0 Cr -2.4% -5.4% -8.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,132.0 Cr -5.8% -4.4% -8.4% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

1.5%

-8%

-7.1%

SENSEX

-2.2%

0.6%

-5.8%


You may also like the below Video Courses